CARDIOLOGY, published by KARGER, is a renowned scholarly journal dedicated to the advancement of research in the fields of cardiology and cardiovascular medicine. Since its inception in 1937, the journal has consistently provided a platform for high-quality, peer-reviewed articles that contribute to the understanding and treatment of heart and vascular diseases. With an impressive convergence through 2024, CARDIOLOGY holds a respectable Q2 ranking in both the Cardiology and Cardiovascular Medicine and Pharmacology (medical) categories, placing it within the 53rd and 45th percentiles of respective Scopus ranks. Based in Switzerland, the journal serves as an essential resource for researchers and practitioners aiming to stay abreast of cutting-edge developments and evidence-based practices in cardiovascular health. While it currently does not offer open access options, its commitment to rigorous scientific standards solidifies its significance within the academic community. We invite readers to explore the latest research findings and contribute to this vital field through publications in CARDIOLOGY.

Cardio-Oncology, published by BMC since 2015, serves as a premier open-access journal dedicated to the intersection of cardiology and oncology, ensuring that vital research reaches a global audience without barriers. With an impactful presence in the United Kingdom and an impressive Q1 ranking in Cardiology and Cardiovascular Medicine, alongside a Q2 ranking in Oncology as of 2023, the journal captures the growing importance of managing cardiovascular health in cancer patients. Aimed at researchers, healthcare professionals, and students, Cardio-Oncology publishes high-quality research, reviews, and clinical studies that advance understanding in this critical field, fostering an interdisciplinary dialogue essential for improving patient outcomes. Accessible and relevant, the journal reflects the concerted effort to bridge gaps in knowledge and address the complexities faced by healthcare providers managing the dual challenges of cancer and cardiovascular disease.

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

Molecular & Cellular Toxicology, published by the Korean Society Toxicogenomics & Toxicoproteomics (KSTT), is a significant journal in the field of toxicology, providing crucial insights into molecular mechanisms underlying toxic responses. With an ISSN of 1738-642X and E-ISSN 2092-8467, this journal serves as a vital platform for researchers, professionals, and students interested in the latest findings and advancements in toxicology, health, and environmental science. Although it operates under a subscription model, it maintains rigorous peer review standards, contributing to its respectable Q3 classification in Health, Toxicology and Mutagenesis, and its Q2 standing in Pharmacology, Toxicology, and Pharmaceutics. The journal, intersecting with innovative aspects of pharmacology and public health, aims to foster a deeper understanding of toxicological impacts on cellular processes and overall health. Located in Germany and supported by a dedicated editorial board, Molecular & Cellular Toxicology stands out in the academic community, encouraging interdisciplinary discourse and collaboration to address critical toxicological challenges. Engage with us for cutting-edge research that informs and shapes the future of toxicological science.

ARCHIVES OF TOXICOLOGY is a prestigious journal published by Springer Heidelberg, dedicated to advancing research in the field of toxicology and related disciplines. With a distinguished history dating back to 1930, this journal has continuously provided vital insights and groundbreaking studies, making it a cornerstone in the areas of health, toxicology, and medicine. Recognized for its high impact, it occupies a top-ranking position in Scopus, with remarkable quartile placements in 2023, categorizing it as Q1 in Health, Toxicology and Mutagenesis, and Q1 in Medicine (Miscellaneous). The journal highlights critical research and innovative methodologies, appealing to a diverse audience of researchers, professionals, and students committed to understanding the complexities of toxic substances and their implications for public health and environmental safety. The journal does not currently offer open access, allowing for a more traditional but rigorous peer-review process that ensures the quality and integrity of every published article. Join the global discourse in toxicological science with ARCHIVES OF TOXICOLOGY, where every contribution furthers the understanding of safety and toxicity in our world.

TOXICOLOGY MECHANISMS AND METHODS is a distinguished peer-reviewed journal dedicated to the advancement of toxicological research, published by Taylor & Francis Ltd. With its ISSN 1537-6516 and E-ISSN 1537-6524, this esteemed journal features critical studies and innovative methodologies in the field of toxicology, aligning with its mission to enhance understanding of biological mechanisms and risk assessment. The journal holds a commendable Q2 ranking in both the Health, Toxicology and Mutagenesis, and Toxicology categories, as well as strong positions in Scopus rankings, reflecting its influence with a 71st percentile rank in Toxicology and a 69th percentile rank in Environmental Health. Researchers, professionals, and students in the toxicology domain will find this journal to be an invaluable resource, offering open access options that foster widespread dissemination of its findings. Since its inception, encompassing converged years from 1991 to 1995 and from 2002 to 2024, the journal remains at the forefront of critical discourse and innovative research methods, making it a vital platform for advancing toxicological science globally.

Toxicology and Environmental Health Sciences is a peer-reviewed journal published by the Korean Society for Environmental Risk Assessment & Health Science, dedicated to advancing the fields of toxicology and environmental health. With an ISSN of 2005-9752 and E-ISSN 2233-7784, this journal serves as a vital platform for researchers, professionals, and students seeking to explore the intricate relationships between environmental risks and public health. Operating from South Korea, it has a converged years span from 2009 to 2024, and currently holds a respectable Q3 quartile ranking in both Health, Toxicology and Mutagenesis and Toxicology. This positions the journal within a critical space for those invested in understanding and mitigating environmental health challenges. Although not an open-access journal, it continues to foster high-impact research, contributing to a better understanding of toxicological sciences and environmental health dynamics. Engage with the latest findings and discussions that shape this evolving field through the insightful articles published herein, reinforcing its importance as a resource for scholars and practitioners alike.

ENVIRONMENTAL TOXICOLOGY, published by Wiley, is a premier academic journal dedicated to the multifaceted study of toxic substances in the environment and their effects on human health and ecosystems. With the ISSN 1520-4081 and E-ISSN 1522-7278, this journal holds a prestigious position in the field, being ranked in the Q1 category across various relevant disciplines, including Health, Toxicology and Mutagenesis, and Management, Monitoring, Policy and Law. The journal regularly publishes high-quality research articles, reviews, and policy discussions aimed at understanding the implications of environmental toxins from 1980 to the present, contributing to the body of knowledge critical for the safety and sustainability of our environment. Researchers and professionals will find a treasure trove of information that not only highlights current trends and methodologies but also sets the stage for future advancements in toxicology. As a key resource, it provides valuable insights necessary for policy-making, environmental management, and public health, reinforcing its significance in the ever-evolving fields of toxicology and environmental science.

The Journal of Toxicological Sciences, published by the Japanese Society of Toxicological Sciences, is a prominent academic journal dedicated to the comprehensive study of toxicology and its related fields. Since its inception in 1976, the journal has provided a vital platform for researchers and professionals to disseminate innovative findings and insights in toxicology, with a focus on both experimental and clinical studies. Positioned in the Q3 quartile across various relevant categories, including Medicine (miscellaneous) and Toxicology as of 2023, the journal plays an essential role in advancing our understanding of toxic substances and their effects on biological systems. Although currently not open access, the journal maintains high academic standards and is indexed in Scopus, ranking #96 in Toxicology. Offering unique perspectives from Japan, it encourages global collaboration and discourse among toxicologists, making it an invaluable resource for students, researchers, and industry professionals alike.